References
Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651–2.
Wan P, Zhao X, Hunasehally RY, Shi R, Zheng J. Propylthiouracilinduced ANCA-positive erythema nodosum treated with thalidomide. Int J Dermatol 2012; 51: 345–8.
Wu R, Li R. Propylthiouracil-induced autoimmune syndromes: 11 case reports. Rheumatol Int 2012; 32: 679–81.
Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology 2008; 47: 1515–20.
Slot MC, Links TP, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a longterm follow-up study. Arthritis Rheum 2005; 53: 108–13.
Balavoine AS, Glinoer D, Dubucquoi S, Wémeau JL. Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: How significant is the clinical problem? Thyroid 2015; 25: 1273–81.
Ujihara M, Ishiguro H, Kodama H, Nishiya K, Ikeda M, Kitamura Y. Anti-thyroid drug-induced antineutrophil cytoplasmic antibody (anca)-associated vasculitis. A case report and review of the literature. Jpn J Dermatol 2002; 112: 1229–40.
Yang J, Yao LP, Dong MJ, et al. Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with Graves’ disease: a median 38-month retrospective cohort study from a single institution in China. Thyroid 2017; 27: 1469–74.
Chen M, Gao Y, Guo XH, Zhao MH. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol 2012; 8: 476–83.
Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves’ disease. Thyroid 2000; 10: 595–9.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hasegawa, A., Fujimoto, A., Yuki, D. et al. PR3-ANCA: a potential biomarker of disease activity for propylthiouracil-induced ANCA-associated vasculitis. Eur J Dermatol 28, 530–531 (2018). https://doi.org/10.1684/ejd.2018.3314
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3314